August 20, 2017 7:35 PM ET


Company Overview of Xinxiang Haibin Pharmaceutical Co., Ltd.

Company Overview

Xinxiang Haibin Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical chemicals including meropenem intermediate, meropenem intermediate MAP, protection meropenem, cilastatin intermediate CDCHA, and imipenem intermediate ADC-13. The company is based in Xinxiang, China.

Development High-tech Industrial zone

Dedong street

Xinxiang,  453007



86 37 3241 2881


86 37 3582 8556

Key Executives for Xinxiang Haibin Pharmaceutical Co., Ltd.

Xinxiang Haibin Pharmaceutical Co., Ltd. does not have any Key Executives recorded.

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Xinxiang Haibin Pharmaceutical Co., Ltd., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at